Sage Journals: Discover world-class research

Abstract

PURPOSE:

To explore the radiomics features of triple negative breast cancer (TNBC) and non-triple negative breast cancer (non-TNBC) based on X-ray mammography, and to differentiate the two groups of cases.

MATERIALS AND METHODS:

Preoperative mammograms of 120 patients with breast ductal carcinoma confirmed by surgical pathology were retrospectively analyzed, which include 30 TNBC and 90 non-TNBC patients. The manual segmentation of breast lesions was performed by ITK-SNAP software and 12 radiomics features were extracted by Omni-Kinetics software. The differences of these radiomics features between TNBC and non-TNBC groups were compared, and the receiver operating characteristic (ROC) curve was used to determine the optimal cutoff value of each radiomics parameter for differentiating TNBC from non-TNBC, and the corresponding area under the curve (AUC), sensitivity and specificity were obtained.

RESULTS:

There were statistically significant differences for 4 radiomics features between TNBC and non-TNBC datasets (P < 0.05). They were the roundness, concavity, gray average and skewness of breast lesions. Compared with non-TNBC, TNBC cases have following characteristics of (1) more round with the roundness of 0.621 vs. 0.413 (P < 0.001), (2) more regular with the concavity of 0.087 vs. 0.141 (P < 0.01), (3) higher density or gray average (67.261 vs. 56.842, P < 0.05), and (4) lower skewness (– 0.837 vs.– 0.671, P = 0.034). AUCs of ROC curves computed using features of the roundness and concavity were both larger than 0.70.

CONCLUSION:

Radiomics features based on X-ray mammography may be helpful to distinguish between TNBC and non-TNBC, which were associated with breast tumor histology.

Keywords

Triple negative breast cancer X-ray mammography quantitative imaging markers evaluation of tumor characteristics

Get full access to this article

View all access options for this article.

References

Piasecka ,

Braun ,

Kordek , et al. , MicroRNAs in regulation of triple- negative breast cancer progression, Journal Of Cancer Research And Clinical Oncology 144(8)(2018), 1401–1411.

Sporikova ,

Koudelakova ,

Trojanec , et al. , Genetic markers in triple-negative breast cancer, Clinical Breast Cancer 18(5)(2018), e841–e850.

Guney Eskile ,

Cecener ,

Egeli , et al. , Triple negative breast cancer: New therapeutic approaches and BRCA status, APMIS 126(5)(2018), 371–379.

Zuo ,

Wilson ,

A.F.

Cicek , et al. , Androgen receptor expression is a favorable prognostic factor in triple-negative breast cancers, Human Pathology 80(2018), 239–245.

A.A.

Luck ,

A.J.

Evans ,

J.J.

James , et al. , Breast carcinoma with basal phenotype: Mammographic findings, Am J Roentgenol 191(2) (2008), 346–351.

Langs ,

Röhrich ,

Hofmanninger , et al. , Machine learning: From radiomics to discovery and routine, Der Radiologe (2018), DOI: 10.1007/s00117-018-0407-3

Thawani ,

McLane ,

Beig , et al. , Radiomics and radiogenomics in lung cancer: A review for the clinician, Lung Cancer 115(2018), 34–41.

Traverso ,

Wee ,

Dekker , et al. , Repeatability and reproducibility of radiomic features: A systematic review, International Journal of Radiation Oncology*Biology*Physics 102(4) (2018), 1143–1158.

J.P.

Foy ,

Durdux ,

Giraud , et al. , RE: The rise of radiomics and implications for oncologic management, J Natl Cancer Inst 110(11) (2018), 1275–1276.

10.

Avanzo ,

Stancanello and

I. El

Naqa , Beyond imaging: The promise of radiomics, Phys Med 38(2017), 122–139.

11.

Y. W.

Park ,

J.M.

Oh ,

S.C.

You , et al. , Radiomics and machine learning may accurately predict the grade and histological subtype in meningiomas using conventional and diffusion tensor imaging, European Radiology (2018), https://doi.org/10.1007/s00330-018-5830-3.

12.

B.H.

Zheng ,

L.Z.

Liu ,

Z.Z.

Zhang , et al. , Radiomics score: A potential prognostic imaging feature for postoperative survival of solitary HCC patients, BMC Cancer 18 (2018), 1148.

13.

W.J.

Ma ,

Y.M.

Zhao ,

Ji , et al. , Breast cancer molecular subtype prediction by mammographic radiomic features, Acad Radiol (2018), https://doi.org/10.1016/j.acra.2018.01.023.

14.

C.S.

Liang ,

Z.X.

Cheng ,

Y.Q.

Huang , et al. , An MRI-based radiomics classifier for preoperative prediction of Ki-67 status in breast cancer, Acad Radiol 25(9) (2018), 1111–1117.

15.

Ocana ,

Pandiella , Targeting oncogenic vulnerabilities in triple negative breast cancer: Biological bases and ongoing clinical studies, Oncotarget 8(13) (2017), 22218–22234.

16.

Bianchini ,

J.M.

Balko ,

L.A.

Mayer , et al. , Triple-negative breast cancer: Challenges and opportunities of a heterogeneous disease, Nature Reviews Clinical Oncology 13(11) (2016), 674–690.

17.

S.K.

Shu ,

C.Y.

Lin ,

H.H.

He , et al. , Response and resistance to BET bromodomain inhibitors in triple-negative breast cancer, Nature 529(7586) (2016), 413.

18.

A.F.

Lin ,

C.L.

Li ,

Xing , et al. , The LINK-A lncRNA activates normoxic HIF1 alpha signalling in triple-negative breast cancer, Nature Cell Biology 18(2) (2016), 213.

19.

M.L.

Telli ,

K.M.

Timms ,

Reid , et al. , Homologous recombination deficiency (HRD) score predicts response to platinum-containing neoadjuvant chemotherapy in patients with triple-negative breast cancer, Clinical Cancer Research 22(15) (2016), 3764–3773.

20.

S.E.

Lee ,

Han ,

J.Y.

Kwak , et al. , Radiomics of US texture features in differential diagnosis between triple-negative breast cancer and fibroadenoma, Scientific reports 8(1) (2018), 13546.

21.

S.C.

Agner ,

M.A.

Rosen ,

S.A.

Englander , et al. , Computerized image analysis for identifying triple-negative breast cancers and differentiating them from other molecular subtypes of breast cancer on dynamic contrast-enhanced MR images: A feasibility study, Radiology 272(1) (2014), 91–99.

22.

J.H.

Youk ,

E.J.

Son ,

Chung , et al. , Triple-negative invasive breast cancer on dynamic contrast-enhanced and diffusion-weighted MR imaging: Comparison with other breast cancer subtypes, Eur Radiol 22(8) (2012), 1724–1734.

A pilot study of radiomics technology based on X-ray mammography in patients with triple-negative breast cancer